Replies to post #293028 on Bioelectronics Corp (BIEL)

[Threepointer]

The problem is that the fda cost them MILLIONS of dollars due to additional studies and resubmissions. They still had normal business expenses in the interim. And now they have partners who are placing products all around the world as well as advertising. Those partners are absorbing those costs. At least give an honest answer when replying.